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INTRODUCTION 
Reduction in perinatal mortality and long-term morbidity remains 
a challenge in modern obstetrics. Antenatal forecasts of fetal health have 
been focus of intense interest in past few decades in obstetrics. The 
methods of forecasting have evolved continually, a phenomenon that 
itself suggests dissatisfaction with efficacy of any given method.  
Among the vast number of biochemical and biophysical 
techniques that have been developed in recent years to predict and 
to improve perinatal outcome, ultrasound has revolutionized the 
practice of obstetrics, its greatest advantage being its noninvasive 
nature. Diagnostic ultrasound since its introduction by Prof Ian 
Donald in 1950 has undergone rapid technological advances. With 
recognition of importance of amniotic fluid in predicting the fetal 
well being, the amniotic fluid evaluation during sonographic 
examination for fetal well being though once relegated to an “after 
thought” is now considered an integral and important part of 
sonographic evaluation of pregnant women. USG is an ideal tool for 
accurately and repeatedly assessing amniotic fluid volume. 
 Manning and colleagues using real time ultrasound device have 
evolved biophysical profile with amniotic fluid volume (AFV) as one of 
the five biophysical variables. Increasing knowledge of strong 
correlation between fetal wellbeing and AFV in high risk pregnancy has 
resulted in evolution of more accurate methods of  AFV assessment by 
USG, one such method is the four quadrant technique or Amniotic Fluid 
Index (AFI) proposed by J.P. Phelan and colleagues. Ultrasound 
estimation of AFI has become critical component of antenatal fetal 
surveillance. Reduction in AFI have classically been considered an 
indication of fetal compromise.  
The present study was undertaken to re-evaluate the relationship 
between AFI and neonatal outcome and effect on labour 
 
 
 
 
 HISTORY AND REVIEW OF LITERATURE 
Platt and co-workers24 reviewed the impact of antenatal fetal 
testing on perinatal outcome between 1971 and 1985 at Los Angeles 
County Hospital. They concluded that such testing was clearly 
beneficial because fetal death rate was significantly less in tested high-
risk pregnancies compared with the rate in those not tested. 
Passive unstimulated fetal activity commences as early as 7 weeks 
and becomes more sophisticated and coordinated by the end of 
pregnancy. Since 1973, when Sadovsky and Yaffy30 described case 
reports of pregnancies with decreased fetal activity that preceded fetal 
death, various methods have been described to quantify fetal movements 
as a way of prognosticating fetal well being which include use of 
tocodynamometer, visulisation with real time ultrasound and maternal 
subjective perceptions. Most investigators reported excellent correlation 
between maternally perceived fetal movements and those documented 
by instruments (Rayburn 1980). Grant and co-workers10 (1989) 
concluded that informal maternal perceptions were as good as formally 
counted and recorded fetal movements. 
 Ray and colleagues26 (1972) developed oxytocin challenge test or 
Contraction Stress  Test (CST). A brief period of hypoxic stress, which 
occurs during CST, is well tolerated by healthy fetus. In presence of 
uteroplacental pathology such hypoxic stress produces late and variable 
fetal heart rate decelerations, which are earliest indicators of fetal 
distress.  
Freeman, Lee and colleagues8 (1985) introduced Non Stress Test 
(NST) to describe FHR accelerations in response to fetal movements as 
a sign of fetal health. It is based on hypothesis that the heart rate of the 
fetus that is not acidotic as a result of hypoxia or neurological 
depression will temporarily accelerate in response to fetal movement. 
By the end of 1970’s the NST has become the primary method of testing 
fetal health as it was non-invasive, easy to perform and interpret and 
readily accepted by the patients. NST was considered normal when 
more than two accelerations of more than 15 bpm above the baseline 
each lasting for more than 15 sec occur in 20mts observation period. 
The main problems with NST are the high false positive results, the 
possibility that a truly abnormal result reflects an advanced rather than 
an early stage of fetal distress. Also the interpretation of NST relies only 
on one variable i.e., presence of accelerations of FHR and ignores that 
other important ones like loss of variability, and presence of 
decelerations. Hoskins and associates11 (1991) attempted to refine 
interpretation of NST with variable decelerations by adding 
ultrasonographic estimation of amniotic fluid volume. 
Vibro Acoustic Stimulation Test (VAST) was originally designed 
to decrease the time spent in performance of NST. Perez, Delboy and 
colleagues21 (2002), concluded that VAST shortened the average time 
for non-stress testing from 24 to 15 minutes. 
Manning and colleagues (1980) proposed the combined use of 
five biophysical variables as more accurate means of assessing fetal 
health than any one used alone. They hypothesized that consideration of 
five biophysical components assessed include FHR acceleration, fetal 
breathing, fetal movements, fetal tone and amniotic fluid volume. 
Normal variables were assigned a score of two each and abnormal 
variables a score of zero. 
Manning and co-authors (1993), Salvesen and colleagues (1993) 
correlated biophysical profile with umbilical venous blood pH obtained 
at cordocentesis. They concluded that BPP was of limited value in 
prediction of fetal. PH. An equivocal result a score of 6 was poor 
predictor of abnormal outcome. A decrease from an abnormal result (a 
score of 2 to 4) to a very abnormal score (i.e., 0) was progressively more 
accurate predictor of abnormal outcome. 
The main problem with BPP is the structure of the test in which 
each of the five variables is assigned a score of either 2 or 0 despite the 
possibility that each of these variables may have different importance in 
assessing fetal situation. Each fetal function evaluated in BPP has 
different predictive value in indicating fetal hypoxia-an assumption that 
was evaluated by Manning in 1990. They found that abnormal NST and 
decreased amniotic fluid volume have higher positive predictive values 
than do fetal movements, fetal tone and breathing movements. 
Vintzileos et al (1987) proposed a modification of biophysical 
profile using NST with vibro acoustic stimulation test and amniotic fluid 
index.The modified BPP combines the observation of an index of acute 
fetal hypoxia(the NST) with an index of chronic fetal problem (the 
AFI).Clark et al used this modified BPP and concluded that this was 
best method of primary antenatal fetal surveillance. 
  Manning et al14 (1981) observed that qualitative amniotic fluid 
volume by ultrasound could be used in antepartum detection of IUGR. 
Philipson et al (1983) have demonstrated clinical association and 
predictive value of oligohydramnios in IUGR.Chamberlain et al3 (1984) 
studied the relationship of marginal and decreased amniotic fluid 
volume evaluated by ultrasound to perinatal outcome and stated that 
gross and corrected perinatal mortality was significantly higher in 
association with decreased qualitative amniotic fluid volume.Crowley et 
al (1984) used ultrasound assesement of amniotic fluid volume to 
monitor patients with prolonged pregnancy and reported that it was an 
effective discriminatory test in post term pregnancy. 
 Phelan JP et al22 (1987) developed the four quadrant 
technique(amniotic fluid index) to identify normal amniotic fluid 
volume at 36-42 weeks gestation.Rutherford et al (1987) have studied 
the four quadrant assesement of amniotic fluid volume as an adjunct to 
antepartum foetal heart rate monitoring and reported an inverse 
relationship between amniotic fluid index and NST,FHR decelaration, 
meconium staining,caesarean section for fetal distress and low Apgar 
score.Phelan et al (1987) studied AFI changed from 11 weeks through 
43 weeks gestation and suggested  that serial measurement of the AFI 
may be an effective means of assessing fetal status throughout 
pregnancy. 
Moore et al20 (1990) studied prospectively amniotic fluid index in 
normal human pregnancy and provided normative data for the amniotic 
fluid index throughout pregnancy. Christopher (1992) compared various 
semi quantitative ultrasonographic measures of amniotic fluid volume 
and concluded that amniotic fluid index is slightly better than maximal 
amniotic fluid vertical pocket in reflecting actual amniotic fluid volume.  
Alfirevic et al (1995) reported that use of amniotic fluid index as 
a test of fetal well being in prolonged pregnancy may lead to more 
obstetric intervention without yet unclear impact on the perinatal 
outcome. 
Gramel et al9 (1997) studied 65 patients with oligohydramnios 
and found higher incidence of premature delivery but no increase in the 
incidence of IUGR, perinatal death or birth asphyxia. Magann et al16 
(1999) and Kreiser et al (2001) also found no increase in poor perinatal 
outcome in cases of isolated oligohydramnios. 
Chauhan et al4 (1999)in a meta analysis of relationship between 
AFI and perinatal outcome concluded that there was an association 
between oligohydramnios and increase incidence of caesarean delivery 
for non reassuring FHR patterns and low Apgar Scores.  
Amniotic Fluid In Normal Pregnancy 
Source: 
The exact origin of amniotic fluid is not yet known. The 
following are the important sources of amniotic fluid. 
1. Transudate from maternal plasma via chorio amniotic membrane 
and maternal circulation in the placenta. 
2. Transudate from fetal circulation in placenta, umbilical cord and 
across the fetal skin before it is keratinized at 24-26 weeks. 
3. Secretion from amniotic epithelium. 
4. In the later half of gestation two primary sources are fetal kidneys 
and lungs. 
In first trimester amniotic fluid is ultra filtrate of plasma 
consisting of extra cellular fluid that diffuses through amniotic 
membrane covering placenta and cord and the embryonic skin, which is 
only 4 cell layers thick. Diffusion across this permeable barrier 
continues until fetal skin keratinization occurs at 24-26 weeks gestation. 
In the second and third trimesters fetal urine plays important role in 
production of amniotic fluid. The excretion of hypotonic urine by fetal 
kidneys starts as early as 12 weeks. At 18 weeks gestation fetal produces 
urine at rate of 7-17 ml. per day and increases steadily throughout 
pregnancy. At term it is approximately 800ml. per day. Fetal lungs also 
contribute to amniotic fluid volume at the range of 60-100ml. per kg 
fetal weight per day at term. The primary sources of removals of 
amniotic fluid are gastrointestinal tract (by swallowing) and absorption 
into fetal blood perfusing surface of placenta. At term fetus swallows as 
much as 50% of total amniotic fluid volume. 
Circulation of amniotic fluid: 
Amniotic cavity is a metabolically active compartment and is 
remarkably dynamic site of fluid volume changes. Plentill (1966) 
demonstrated the dynamic of amniotic fluid circulation using sodium 
and deuterium oxide. At term the circulation time allowing complete 
change over of amniotic fluid is around 3 hours. The volume of amniotic 
fluid at any moment represents a balance between those structures 
producing or allowing passage of fluid into amniotic cavity i.e. chorion 
frondosum, membranes, skin, urinary and respiratory tract and those 
involved in removal of amniotic fluid i.e. gastrointestinal tract and 
amniochorionic interface.There are two additional pathways- 
intramembranous and transmembranous. The more important 
intramembranous pathway includes transfer between amniotic fluid and 
fetal blood perfusing the fetal surface of placenta, fetal skin and 
umbilical cord. The transmembranous pathway involves exchange 
across the fetal membranes between amniotic fluid and maternal blood 
within wall of uterus. At term the exchange between maternal blood and 
amniotic fluid is small and negligible where as intramembranous flow 
reaches nearly 400ml. per day. 
Volume of amniotic fluid: 
Weismann, Itskovitz, Eldor, Jakobi, calculated amniotic fliuid 
volume at different gestational ages. They found that amniotic fluid 
increased from approximately 1 ml. at 7 weeks to 25ml at 10 weeks, 
60ml at 12 weeks, 400ml at 20 weeks and peaks at around one litre 
between 35-36 weeks. During last weeks of pregnancy the amniotic 
fluid volume decreases. Beyond 40 weeks the amniotic fluid volume 
decreases further. The amount of amniotic fluid is 480ml, 250ml, 160ml 
at 42,43,44 weeks respectively. But the rate of decline of amniotic fluid 
is unpredictable in post term pregnancies, abrupt fall can occur within 
24hrs. 
Brace and Wolf found that amniotic fluid volume progressively 
rises from 8 weeks gestation reaching its statistical maximum (variance 
analysis) at 32 weeks. These authors calculated the mean changes in 
amniotic fluid volume on weekly basis (based on polynomial regression 
equation). 
Characteristics of amniotic fluid: 
Physical: 
 Specific Gravity –  Early pregnancy –  1006 
    Late Pregnancy –  1081  
 PHat term – 7.04 to 7.11 
 Osmolality 20-30mOsm./ltr. 
 Colour: During early pregnancy amniotic fluid is colourless and 
gradually becomes pale straw to deep yellow colour depending on the 
amount of bilirubin. Bilirubin concentration decreases after mid 
pregnancy and after 36 wks. Amniotic fluid becomes colourless but 
cloudy due to admixture of vernix caseosa (which are clumps of 
desquamated fetal skin cells and free lipid material) lanugo hair and 
epithelial cells. 
Chemical composition: 
In early pregnancy composition is same as maternal plasma with 
lowered proteins. 
Composition at term: 
1. Water – 98-99.5% 
2. Solid 1-2% 
Organic – 50% 
Inorganic – 50% 
 Organic – 50% of organic constituents are proteins and their 
derivatives. 
 1. Proteins and their derivatives – 0.25g% 
  Albumin – 60% 
  Ceruloplasmin – 1.5% 
  Transferrin – 11.6% 
  IgA- 0.1% 
  IgG- 11% 
  Alpha feto protein 
  Amino Acids – Similar to that in maternal plasma 
 2.  Glucose – 20 mg% 
 3.  Uric Acid – 4 mg% 
 4.  Creatinine – 1.8 mg% 
 5.  Vitamins 
6. Enzymes : Alkaline Phosphatase, Acid Phosphatase,  
                                        Monoamine  oxidase, Lysozyme. 
 7. Hormones: 
 8. Lipids 
9. Bilirubin 
10.Prostaglandins 
Inorganic: 
1. Electrolytes: During first half of pregnancy sodium and chloride 
concentrations are similar to fetal than maternal serum. Later the 
fluid becomes progressively hypotonic with decreased sodium 
and chloride concentrations and a corresponding fall in osmotic 
pressure. These changes associated with gradual rise in uric acid 
and creatinine levels reflect the contribution of maturing fetal 
renal function to amniotic fluid. Potassium, Calcium, Magnesium, 
Phosphorus, Zinc, Iron and Sulphur are also present with no 
significant changes as pregnancy advances.  
2. Gases: Johnson and Ojo reported a positive correlation between 
maternal hematocrit values and amniotic fluid PaO2 in 1967. Pa 
CO2 in amniotic fluid near varies from 44.0-57.6mm Hg.(Kittrich 
1968). 
3. Cells: Nucleated and anucleated cells derived from fetal skin, 
buccal and respiratory mucosa, bladder, vagina, umbilical cord, 
and amniotic epithelium. 
Functions of amniotic fluid: 
During Pregnancy 
a. Amniotic fluid acts as a cushion to allow normal musculoskeletal 
development of fetus free from restriction or distortion by 
adjacent structures. 
b. It maintains even temperature and provides thermally stable 
environment. 
c. It acts as a shock absorber protecting the fetus from possible 
trauma. 
d. It allows free movement of fetus and prevents adhesions between 
fetal parts and amniotic sac. 
e. It has minimal nutritive value. 
f. It has epidermal growth factors (EGF and EGF like growth 
factors e.g. transforming growth factor β). Ingestion of amniotic 
fluid into GIT and inhalation into lungs may promote growth and 
differentiation of these tissues. 
During Labour: 
1. It helps in dilatation of birth passage by forming a wedge of 
the bag of membranes. 
2. It protects fetus and placenta from pressure by contracting 
uterus. 
3. It flushes the vagina before birth of the baby and by its 
antiseptic and bactericidal action protects the fetus and 
prevents ascending infection into uterine cavity. 
4. It serves as a biological medium in which various bioactive 
substances are temporarily stored. Half life of selected 
compounds in amniotic fluid is much longer than those of 
same compounds in blood. For eg. t ½ of PGF2 α and PGE2 
in plasma is 6-8 mts whereas in amniotic fluid it is 4-6 hrs. 
Methods to assess amniotic fluids: 
Amniotic fluid reflects uteroplacental perfusion, fetal metabolism 
and renal function. Changes in AFV may be related to wide variety of 
physiological and pathological changes in fetus and mother. Clinical 
assessment of amniotic fluid volume is usually subjective, although 
most experienced clinicians are capable of making this subjective 
assessment, lack of objectivity is troublesome and cannot be relied upon 
in planning the management of high risk pregnancies. Hence efforts 
were made by various workers to devise convenient and reproducible 
methods for estimation of amniotic fluid volume. 
1. Ultrasonography: USG is an ideal non-invasive tool for accurate 
and repeated assessment of amniotic fluid volume. 
Ultrasonographic visualization of amniotic fluid may be 
subjective or semiquantative. 
¾ Subjective: the technique of subjective assessment of AFV 
involves comparing echo free fluid areas  surrounding the fetus 
with the space occupied by fetus and placenta. This allows 
sonographer to visually integrate multiple pockets of amniotic 
fluid into a subjective total that is compared with expected 
normal level at each stage of gestation. Halperin et al evaluated 
inter and intraobserver variability in subjective assessment of 
AFV.  
¾ Non – Quantitative Assessment: Crowley described a simplified 
method of estimating AFV based on quantity of amniotic fluid 
seen by USG in the area of fetal limbs. Amniotic fluid was 
considered normal if pocket of fluid was demonstrated between 
the fetal limbs and anterior and posterior wall. It was considered 
reduced, if the pocket was seen only between limbs, and as 
absent if no pocket was seen. 
¾   Semi-Quantitative Approaches: Their technique involves 
scanning the uterus to select single deepest amniotic fluid 
pocket free of umbilical cord and fetal parts. The greatest 
vertical dimension of this pocket is then measured at right angle 
to the uterine contour, thus excluding errors related to uterine 
venous drainage, using transducer perpendicular to the floor. 
This measurement has been referred as maximum vertical 
pocket (MVP). The width of the largest pocket was measured at 
right angles to the depth measurement in order to exclude errors 
related to the umbilical cord which may, especially in cases of 
severe oligohydramnios be mistaken for amniotic fluid. The 
depth of a pocket was used to classify the cases into-decreased 
(<1cm), marginal (1-2cm), normal (2-8cm) and excess (>8cm). 
The choice of less than 8cm of normal amniotic fluid was 
arbitrary and based upon a clinical impression gained while 
performing biophysical profile scoring. 
In 1987 Phelan et al and subsequently Rutherford, Moore and 
Cayle developed a semiquantitative method of sonographic assessment 
of amniotic fluid index. This method is based on division of gravid 
uterus into four quadrants using external landmarks on maternal 
abdomen-transverse line through the umbilicus divides the abdomen 
transversely into upper and lower halves and the lineanigra divides it 
into right and left halves. 
 
Technique For Measurement Of Amniotic Fluid Index 
(Adapted from Moore TR, Clinical assessment of AFI, Clinical 
Obst and Gyn 40:2; 300, 1997)  
¾ Patient in supine position 
¾ A liner curvilinear or sector transducer can be used 
¾ Dividing the uterus into four quadrants using maternal 
sagittal midline vertically and arbitrary transverse line 
approximately halfway between the symphysis pubis and 
the upper edge of uterine fundus. 
¾ The transducer must be kept parallel to the maternal sagittal 
plane and perpendicular to the maternal coronal plane 
throughout. 
¾ The deepest unobstructed and clear pocket of amniotic fluid 
is visualized and image frozen. The US calipers are 
manipulated to measure the pocket in a strictly vertical 
direction. 
¾ The process is repeated in each of the four quadrants and 
pocket measurements are summed to get amniotic fluid 
index. 
¾ If AFI is less than 8 cm the four-quadrant evaluation is 
performed 3 times and average values are taken. 
In a 1997 review Hill noted that Phelan et al’s original description 
of AFI did not mention whether the pockets of amniotic fluid containing 
umbilical cord should be included or excluded. Rutherford et al 
subsequently stated that umbilical cord or an extremity may traverse a 
pocket of measured amniotic fluid. However when the pocket is almost 
entirely filled with either umbilical cord or extremities, it should not be 
included as one of the measured pockets. 
 
 
 
Table A: Amniotic Fluid Index values in normal pregnancy 
 
(Moore and Cayle Am.J.O.G. May 1990). 
 
 
AFI Percentile Values  
Week 
 
2.5th 5th 50th 95th 97.5th
 
N 
16 73 79 121 185 201 32 
17 77 83 127 194 211 26 
18 80 87 133 202 220 17 
19 83 90 137 207 225 14 
20 86 93 141 212 230 25 
21 88 95 143 217 233 14 
22 89 97 145 216 235 14 
23 90 98 146 218 237 14 
24 90 98 147 219 238 23 
25 89 97 147 221 240 12 
26 89 97 147 222 242 11 
27 85 94 146 226 245 17 
28 86 94 146 228 249 25 
29 84 92 145 231 254 12 
30 82 90 145 234 258 17 
31 79 88 144 238 263 26 
32 77 86 144 242 269 25 
33 74 83 143 245 274 30 
34 72 81 142 248 278 31 
35 70 79 140 249 279 27 
36 68 77 138 249 279 39 
37 66 75 135 244 275 36 
38 65 73 132 236 269 27 
39 64 72 127 226 255 12 
40 63 71 123 214 240 34 
41 63 70 116 194 216 162 
42 63 69 110 174 192 30 
 
 
 
DEFINITION OF OLIGOHYDRAMNIOS 
 
(From Hill LM: Oligohydramnios – Sonographic diagnosis and clinical 
implications clinical Obs and Gyn 40:2:314, 1997). 
 
Technique Definition of 
Oligohydramnios 
Study 
Dye dilution method 200ml Horsager, Nathan & 
Leveno 
Ultrasound Single vertical pocket 
<1cm 
Manning, Hill & Platt 
Ultrasound Single vertical pocket 
<3cm 
Halperin et al 
Ultrasound AFI <5th % tile for gest 
age 
Moore & Cayle 
Ultrasound AFI <5cm Phelan et al 
Ultrasound AFI <8cm Jeng et al 
 
Moore and Cayle defined oligohydramnios when AFI was less 
than 5th percentile which corresponded to an AFI of less than 7-8cm. 
Rutherford et al used 5cm as a threshold to define oligohydramnios, a 
number that would be slightly less than the first percentile. Although 
controversy still exists a to which threshold values to use, values greater 
than 5 cm and less than 18-20 cm are considered by most examiners to 
be normal. 
Clinical Significance of Amniotic Fluid in Obstetrics 
1.  Prenatal Diagnosis of Genetic Diseases 
Cultured amniotic fluid cells can be utilized for cytogenetic 
studies as well as enzyme and DNA analysis. The success rate for 
amniotic fluid cell growth and cytogenetic studies approaches 98 to 99 
percent. The fluid itself can be utilized for measuring a variety of 
substances such as AFP, acetylcholine esterase etc which may provide 
useful clues as to the presence or absence of fetal disorders. Amniotic 
fluid cells can be obtained by amniocentesis most often performed at 16 
to 18 weeks gestation when it is likely that there are sufficient fetal cells 
to allow successful culture. But recent reports suggest that early 
amniocentesis performed before 15 weeks also had surprisingly high 
rate of success, which exceeded 95 percent. The cytogenetic success is 
also high approaching 99 to 100 percent (Penso and Frigoletto 1990). 
Fetal karyotyping can be done using the shed fetal cells obtained by 
amniocentesis. Sex of the fetus can also be determined by using 
amniotic fluid cells in some patients with history of x linked recessive 
disorders where pregnancy may have to be terminated if the fetus is 
male. 
2.  Fetal lung maturity tests: 
 Delivery for fetal indications is necessary when risk to the fetus 
from hostile intrauterine environment is greater than the risk of 
respiratory distress, even if the fetus is preterm. Amniotic fluid obtained 
by amniocentesis is utilized to determine the relative concentration of 
surfactant active phospholipids to confirm fetal lung maturity. 
Biochemical maturation of fetal lungs is assessed by concentration of 
phospholipid in amniotic fluid obtained by amniocentesis. The 
incorporation of this fact into day to day management of obstetric 
patients has been very important decisions regarding timing of delivery 
of fetus. 
Several methods have been used to estimate concentration of 
pulmonary surfactant and thus predict respiratory distress. 
a . Lecithin Sphingomyelin (L;S) Ratio:  
This was the first reliable test to determine the biochemical 
maturation of the fetal lungs. Before 34 weeks the concentration of 
lecithin and sphingomyelin is similar. After 34 weeks the concentration 
of lecithin relative to sphingomyelin begins to rise. The incidence of 
respiratory distress was 40% in those with ratio 2-1.5 and 73% in those 
with ratio less than 1.5. 
The main drawback of L/S ratio is that it is not useful in 
predicting respiratory distress in cases of patients with pregnancy 
complications like diabetes mellitus erythroblastosis fetalis, fetal 
neonatal sepsis, or any event that causes serious metabolic fetal 
compromise. 
b. Phosphotidyl Glycerol:  
Surfactant action insufficient to prevent respiratory distress even 
though the L/S ratio is >2 is though to be due in part to lack of 
phosphotidyl glycerol. Phosphotidyl glycerol appears in amniotic fluid 
usually after 36 weeks and is marker of final biochemical maturation of 
fetal lungs. 
c. Foam Stability test (Shakes Tests): 
 To reduce time, cost and effort inherent in precise measurement 
of L/S ratio, the foam stability or so called shake test was introduced by 
Clements in 1972. The test depends upon the ability of surfactant in 
amniotic fluid to generate stable bubbles when mixed with appropriate 
quantity of ethanol. It is almost 100% accurate when it predicts maturity 
but is poor predictor of pulmonary immaturity. 
3.  Amniotic Fluid absorbance at 650nm:  
The degree of absorbance of light at 650nm wavelength has been 
reported to correlate well with the L/S ratio in amniotic fluid. It can be 
used as screening test and the value between 0.01 and 0.20 should 
prompt further evaluation with other tests for lung maturity. 
4.  Erythroblastosis fetalis: 
 In pregnancies affected by the presence of incomplete antibodies 
capable of producing erythroblastosis fetalis, spectrophotometric 
analysis of the amniotic fluid is reliable method of evaluating the 
severity of fetal haemolytic process and for determining the optimal 
time for intra uterine transfusion or for delivery of the infant. Amniotic 
fluid analysis is mandatory in management of the Rh negative 
isoimmunised gravidae in all her pregnancies except for the sensitized 
pregnancy during which she can be managed depending on antibody 
titre. The follow up with amniocentesis is of particular importance for 
those patients with histories of prior deliveries of infants with 
erythroblastosis. 
5. Amniotic Fluid Volume 
Polyhydramnios: 
 Polyhydramnios is a clinical condition characterized by amniotic 
fluid exceeding arbitrary volume of 2000ml. It affects approximately 0.4 
to 1.5 percent of all pregnancies. Based on ultrasonographic findings, 
hydramnios may be defined as finding of amniotic fluid pocket 
measuring 8 cm or more in vertical diameter or an amniotic fluid index 
greater than 25 cm. Traditionally, hydramnios has been classified as 
acute when it occurs before 24 weeks of gestation and chronic when it 
the diagnosis is made in the third trimester. 
Etiology: 
A. Maternal Causes: 
¾ Rh isoimmunisation: With use of prophylactic anti D Ig this 
condition has become an uncommon cause of hydramnios. About 
20 yrs back, Rh isoimmunisation accounted for 11.5% of all cases 
of hydramnios, while more recently it is less than 1% 
¾ Diabetes Mellitus: It is responsible for approximately 14% of all 
cases of hydramnios, and 15 to 66% of all diabetic pregnancies. 
The exact cause is not known. Fetal hyperglycemia with polyuria 
and increased osmolarity of the amniotic fluid caused by high 
glucose concentration have been proposed. 
B. Placental Causes: 
¾ Placental chorioangioma 
¾ Circumvallate placenta syndrome 
C. Fetal Causes: 
¾ Multiple Pregnancies: It accounts for 4.9% of all cases of 
polyhydramnios. Polyhydramnios has been reported in 25% of 
monozygotic twins to twin transfusion syndrome. 
¾ Fetal Anomalies: These are responsible for approximately 12.7% 
of all the cases of Polyhydramnios. The most common lesions are: 
i. Gastrointestinal abnormalities: Include oesophageal atresia, 
annular pancreas, jejunal atresia, diaphragmatic hernia, 
duodenal atresia, omphalocele, gastroschisis and midgut 
volvulus. 
ii. Central nervous system abnormalities: Include 
anencephaly, hydrocephaly, encephalocele, spina bifida, 
microcephaly, holoporencephaly and hydrancephaly. 
iii. Genitourinary abnormalities: Partial or incomplete renal 
obstruction ureteropelvic obstruction. 
iv. Fetal Tumours: Include cystic congenital adenomatied 
malformation of the lung, sacrococcygeal teratoma and 
malignant cervical teratoma. 
v. Skeletal Malformations: Include arthrogryposis, osteo 
genesis imperfacta, achondroplasia, thanatophoric 
dearfism. 
vi. Cardiac abnormalities: Include severe congenital heart 
disease and persistent cardiac arrhythmias. 
vii. Chromosomal abnormalities: The most frequent are Downs 
syndrome trisomies 13 and 18. 
viii. Genetic Syndromes: Include hydrolethalis syndrome, 
Myotonica dystrophica and Shokier syndrome. 
ix. Intrauterine Infections: Rubella, Syphilis, Toxoplasmosis 
x. Heamatological causes: Homozygous alpha thalassemia 
and fetomaternal hemorrhage. 
xi. Idiopathic: In more than 65% of cases polyhydramnios 
does not any specific cause. 
Complications 
A. Maternal 
 Antenatal: Preeclampsia 
   Malpresentations 
   Premature rupture of membranes 
   Preterm Labour 
   Accidental Haemorrhage 
   Respiratory discomfort 
 Intrapartum: Early rupture of membranes 
   Cord Prolapse 
   Uterine Intertia 
   Increased Operative delivery 
   Retained Placenta 
   Postpartum haemorrhage 
 Postpartum: Sub Involution 
B. Fetal: 
 Fetal complications occurs in 16 to 69% of cases. Most common 
causes include. 
1. Congenital anomalies incompatible with life 
2. Prematurity 
3. Cord prolapse 
4. Hydrops fetalis 
5. Increased operative delivery 
6. Accidental haemorrhage 
Oligohydramnios: 
 It is a clinical condition characterized by an abnormally low 
volume of amniotic fluid. Based on ultrasonography findings it can be 
defined as AFI less than 5 cm. 
Etiology: 
A. Post Term pregnancy: The volume of amniotic fluid decreases 
with increasing gestational age after term. An amniotic fluid of 
less than 400 ml at 40 weeks or more is associated with fetal 
complications. The mechanism of oligohydramnios in prolonged 
pregnancy seems to be diminished fetal urine production. IUGR: 
Oligohydramnios is a common finding in severe IUGR. The most 
likely cause of oligohydramnios in IUGR babies is decreased fetal 
urinary output caused by redistribution of the blood flow with 
preferential shunting to the brain and decrease in renal perfusion. 
The incidence of IUGR in presence of oligohydramnios is 40% 
B. Fetal congenital anomalies: Severe fetal congenital 
abnormalities may be associated with oligohydramnios. Most 
common being those which affect the urinary system especially 
renal agenesis, uretheral obstruction, Prune belly Syndrome, 
bilateral multicystic dysplastic kidneys, etc. The non renal causes 
of oligohydramnios include triploidy, thanatophoric dwarfism, 
thyroid gland agenesis, skeletal dysplasia, congenital hear block, 
etc. 
C. Occasional undetected PROM and leaking amniotic fluid: 
This may be confused with excessive vaginal discharge by the 
patient. Leaking fluid following amniocentesis can affect less than 
1% of the patients undergoing these procedures. 
D. Monozygotic Twins: Oligohydramnios affects the donor twin in 
cases with twin to twin ttransfusion syndrome. 
E. Drugs: ACE inhibitors, Indomethacin, etc. 
Complications 
Antenatal: 
¾ Fetal Wastage. 
¾ Congenital postural deformities: Mechanical factors arising 
from chronically low volumes of amniotic fluid and 
restrictions imposed by the small size and inappropriate shape 
of the uterine cavity may mould the growing fetus into distinct 
pattern of deformity including talipes, scoliosis, hip dislocation 
limb reduction and body wall defects. 
¾ Pulmonary Hypoplasia 
¾ Amniotic Bands: Focal ring constrictions of the extremities 
and actual loss of a digit or a limb are rare complications of 
oligohydramnios. 
Intrapartum 
1. Cord compression: Results in intrapartum fetal distress and high 
incidence of operative intervention. 
2. Abnormal Labour: Firm contraction of the uterus over the fetus in 
the absence of amniotic fluid interferes with normal progress of 
labour. 
6. Amnioifusion 
 In presence of oligohydramnios the incidence of cord 
compression and intrapartum fetal distress can be reduced by infusion 
with warm normal saline. In various studies it has been noted that 
amnioinfusion significantly lower rates of meconium passage, server 
variable declerations, end stage bradycardia and operative intervention 
for fetal distress. 
 
 
 
 
 
 
 
  
 
 
AIM OF THE STUDY 
1. To study amniotic fluid index in 1500 women with 37  completed 
weeks of gestation in normal pregnancies 
2. To study the correlation between amniotic fluid index and 
variables like NST, mode of delivery, colour of liquor, neonatal 
morbidity and mortality. 
 
 
MATERIALS AND METHODS 
This descriptive follow-up study was conducted among 1500 
women at Government  Hospital for Women and Children, Egmore, 
Chennai from June 2006 to June 2007. 
Inclusion Criteria: 
1. Patients with correct dates or having early USG 
2. Singleton live pregnancy 
3. vertex presentation. 
4. Gestational age between 37-42 weeks 
5. Membranes intact. 
6. True Labour pains 
7. AFI estimated by four quadrant technique at admission. 
8. Admission CTG done in all cases 
Exclusion criteria: 
1. Patients with LMP not known or those not having early trimester 
USG to confirm the gestational age. 
2.  Multiple pregnancies. 
3.  Non vertex presentation 
4.  Pregnancies less that 37 weeks 
5.  Premature rupture of membranes 
6.  False pains  
7.  Previous caesarean section 
8. Associated maternal complications. 
9.  Patients with fetus having congenital malformations diagnosed by 
USG. 
10.  Intra uterine death. 
All the patients had come to labourward. A careful clinical history 
was taken in each case relating to demographic data, previous obstetric 
history, last menstrual period, previous menstrual cycle and present 
obstetric complications if any. Only those patients with a definitely 
known LMP and / or an early scan report showing gestational age were 
included in the study. 
A thorough clinical examination including height, weight, and 
presence of anaemia, oedema, and blood pressure was done. By 
obstetric palpation, gestational age, presentation and amount of liquor 
noted. The fetal heart sounds were auscultated. All preliminary base line 
investigations like HB% blood grouping and typing, complete urine 
examination and random blood sugar were done. 
A NST was done in all patients on admission. AFI was measured 
in these patients using linear array real time B scan. Examination was 
performed with patients in supine position. External landmarks of 
maternal  abdomen were used to divide the gravid uterus into four 
quadrants. Umbilicus was used to divide it into right and left halves. The 
linear transducer head was placed along mother’s longitudinal axis and 
held perpendicular to the floor for all measurements. The maximum 
vertical diameter of the largest fluid pocket was measured in centimeters 
in each of the four quadrants. Vertical was defined as perpendicular to 
the transducer head. Brief appearance of cord or an extremity was 
ignored. However when the pocket was almost entirely filled with either 
cord or extremity it was not included as one of the measured pockets. 
The measurements obtained from each quadrant were summed up to 
obtain the amniotic fluid index. 
Measurement of variables included are incidence of no reactive 
NST, caesarean delivery for fetal distress, Apgar score < 7 at 5 mts, 
birth weight, meconium staining of liquor, admission to NICU and 
neonatal deaths. 
In this study patients were grouped into four categories based on 
AFI. As per standard definition by Moore TR, 1997 one group had 
oligohydramnios(AFI <5cm) and one group had polyhydramnios(AFI 
>25 cm). The interval of AFI 5-25cm has been divided into two groups 
as 5-8 and 8.1-25 cm taking into consideration the study of Jeng et al 
with cutoff as <8 cm as oligohydramnios and as per Williams obstetrics 
22nd edition, AFI in majority of normal pregnancies ranges from 8-24 
cm. In my study also there was increased neonatal morbidity and 
mortality in the range 5-8 cm. Thus this range has been separated to 
study the importance and significance.  
Chisquare statistical test was applied to find out if there is any 
association between the AFI level and variables studied. 
Odds ratio was used to assess the strength of association.The AFI 
level 8.1-25 has considered as reference category . All the other three 
levels have been considered and expressed with 95% CL (confidence 
limit) of odds ratio. 
RESULTS AND ANALYSIS 
 In this study, 1500 antenatal cases of term gestation were 
included. The study was divided into 4 categories based on AFI and the 
correlation between amniotic fluid index and variables studied like NST, 
mode of delivery, colour of liquor, Apgar at 5 mts, birth weight ,IUGR, 
NICU admission of babies and neonatal death. 
TABLE: 1 
DISTRIBUTION OF AFI IN THE STUDY GROUP 
 
Total No of 
Cases 
AFI  <5 cm AFI 5 – 8 
cm 
AFI  8.1-25 
cm 
AFI >25 cm 
1500 147 360 975 18 
 
This table shows the distribution of AFI in the study group.Out of 
1500 cases studied 147 had oligohydramnios, defined as AFI <5 cm, 
360 had AFI in the range of 5-8 cm, 975 had AFI in the range of 8.1- 25 
cm and 18 had polyhydramnios defined as AFI >25 cm. 
 
 
 
 
 
TABLE: 2 
 
AFI & ADMISSION TEST 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Cases  147 360 975 18 
Non 
Reactive 
NST 
84  
(57.14%) 
84  
(23.33%) 
78  
(8%) 
3  
(16.66%) 
Reactive 
NST 
63  
(42.85%) 
276 
(76.66%) 
897  
(92%) 
15  
(83.33%) 
 
χ2 = 243.6          df= 3 pvalue < 0.001 
  AFI(cm)             Odds ratio (OR)   95% CL  
                                 Lower range  Upper range 
<5 :                  15.9            10.659  23.853 
5-8 :                  3.64  2.59   5.11 
>25 :                 2.39  0.677   8.447(NS) 
  
 Among the patients with AFI<5, 57.14 % of them were having 
nonassuring fetal heart pattern, 23.33% of the patients with AFI 5-8 
were having nonassuring fetal heart pattern,16.66% of the patients with 
AFI>25 were having nonassuring fetal heart pattern, where as only 8% 
of the patients were having non assuring fetal heart pattern in the 
patients with AFI 8.1-25 cm. 
 This has an OR of 15.9 which indicates 16 times chances of 
having non assuring fetal heart pattern when AFI<5cm.compared to AFI 
group of  8.1-25 cm. 
 The group of patients with AFI 5-8 cm had an OR 3.6 or 3.6 times 
higher risk of non reassuring NST, whereas in cases of with AFI >25cm 
the risk of non reassuring NST was clearly 2.4 times that of AFI group 
of 8.1-25cm (OR = 2.39) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE:3 
 
AFI & MODE OF DELIVERY 
 
 
AFI  
 
<5 cm 5-8 cm 8.1-25 cm >25 cm 
Cases   147 360 975 18 
SPVD 12  
(8.16%) 
168 
(46.66%) 
654 
(67.07%) 
12 
(66.66%) 
Induced 24 
(16.32%) 
45 
(12.60%) 
72  
(7.38%)  
 
Vaginal 
Forceps 12  
(8.16%) 
15  
(4.16%) 
48  
(4.92%)  
Total 
Vaginal 
Delivery 
 48 
(32.65%) 
228 
(63.33%) 
774 
(79.2%)  
Total Emergency 
caesarean sections  
99  
(34%) 
132 
(36.66%) 
201 
(27.6%) 
6 
(33.33%) 
 
χ2 =1480 df = 3  pvalue:>0.001. 
AFI (cm)  OR                                    95%CL 
      Lower Upper 
<5 :   7.942   5.442  11.591 
5-8:   2.229   1.711   2.905 
>25:   1.925   0.714  5.193(NS) 
 Among the patients with AFI  <5, 34% underwent caesarean 
section, 36.66% underwent caesarean section in the patients with AFI 
level 5-8,33.33% underwent caesarean section in the group of AFI>25 
cm whereas only 27.6% patients with AFI level 8.1-25 cm underwent 
caesarean section. 
 OR 7.9 indicates chances of having caesarean section is 7.9 times 
higher in AFI group <5 cm and OR of 2.22 indicates chances of having 
caesarean section is 2.2 times higher in AFI group of 5-8 cm compared 
to AFI group 8.1-25 cm. 
 Spontaneous vaginal delivery occurred in 67.07% with AFI 8-
25cm, contrasting against 8.16% with AFI<5cm and 46.66% with AFI 
5-8cm.Patients with AFI>25 cm had an incidence of spontaneous 
vaginal delivery approaching that of normal AFI group. 
Similarly induced labour was also higher in the groups AFI < 5 
cm (16.32%), AFI 5-8 cm (12.6%) compared to 7.38% in AFI 8.1-25cm. 
Forceps delivery was 8.1% in those with AFI <5cm, 4.16% in 
AFI 5-8cm and 4.92% in AFI 8.1-25cm.    
 
 
 
TABLE: 4 
 
AFI & INDICATION FOR CAESAREAN SECTION 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Cases 147 360 975 18 
Caesarean 
Section 99 132 201 6 
Fetal distress 84 
(57.14%) 
93 
(25.83%) 
126 
(12.92%) 
3  
(16.66%) 
Failed Induction 9  
(6.12%) 
15  
(4.16%) 
12  
(1.23%)  
CPD 3  
(2.04%) 
21  
(5.83%) 
57  
(5.84%) 
3  
(16.66%) 
Others:like 
Persistent  
3  
(1.36%) 
3  
(0.83%) 
6  
(0.61%)  
Occipitopositerior 3 1 2  
DTA - - 2  
Failure to 
Progress - 2 2  
 
pvalue : <0.001 
 This table shows that fetal distress is commonly associated with 
low AFI groups and it is the leading indication for emergency caesarean 
section in these groups. 
 
 
TABLE:5 
 
AFI & COLOUR OF LIQUOR 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Cases 147 360 975 18 
Clear 45  
(30.61%) 
264  
(73.33%) 
903  
(92.61%) 
15  
(83.33%) 
Thin 42  
(28.57%) 
39  
(10.83%) 
39  
(4%) 
3  
(16.66%) 
Thick 60  
(40.81%) 
57  
(15.83%) 
33  
(3.38%) 
- 
 
χ2= 360.4 df=6 pvalue : <0.001 
 
 Incidence of meconium staining liquor was higher in group with 
AFI< 5 cm and in group with AFI 5-8 cm  compared to AFI group 8.1-
25 cm. 
  
 
 
 
 
 
 
 
TABLE: 6 
 
AFI & APGAR AT 5 MINUTES 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Cases  147 360 975 18 
<7 75  (51.02%) 
90  
(25%) 
132 
(13.53%) 
6  
(33.33%) 
>7 72  (48.97%) 
270 
(75%) 
843  
(`86.46%) 
12  
(66.66%) 
 
 
χ2=120.5 df=3 P<0.001 
   AFI(cm)  OR     95%CL 
     Lower    Upper 
<5   6.652  4.587   9.648 
5-8   2.129  1.576   2.876 
>25   3.193  1.178   8.654. 
 Among the patients with AFI < 5, 51.02% of them had <7 Apgar 
at 5mts, 25% of the patients with AFI 5-8cm  had <7 Apgar at 5mts, 
33.33% of the patients with  AFI>25 cm had <7 Apgar at 5mts whereas 
only 13.53% of patients with AFI of 8.1-25 cm had babies with Apgar 
<7 at 5mts. 
 OR 6.6 indicates the chances of having babies with Apgar score 
<7 for patients with AFI level <5 is 6.6 times and OR of 2.1 indicates 
chances of having babies with Apgar score <7 for patients with AFI 
level 5-8 is 2 times and OR of 3.19 indicates, chances of having babies 
with Apgar score <7 at 5mts 3.2 times with AFI level >25 cm compared 
to women with AFI level 8.1-25cm. 
 
 
 
 
 
TABLE:7 
 
AFI & BIRTH WEIGHT 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Live Birth 147 360 975 18 
<2.5 kg 51  (34.6%) 
42  
(11.66%) 
27  
(2.76%) 
3  
(16.66%) 
2.5-4kg 93  (63.26%) 
315  
(87.5%) 
946 
(97.02%) 
13  
(72.22%) 
>4kg 3  (2.04%) 
3  
(0.83%) 
2  
(0.20%) 
2 
(11.11%) 
 
 
χ2= 182.735 df=3 p<0.001 
  AFI(cm)       OR         95%CL 
      Lower   Upper 
<5    18.653  11.184  31.11 
5-8    4.637    2.813  7.645 
>25    7.022   1.919   25.895 
 Among the patients with AFI level <5, 34.6% of them had babies 
with birth weight <2.5kg,12% of the patients with  AFI level 5-8cm had 
babies with birth weight <2.5kg whereas only 3% of patients with AFI 
level 8.1-25 cm were having babies with birth weight <2.5kg. 
 OR 18.6 indicates the chances of having babies with birth weight 
<2.5kg is 18.653 times higher in patients with AFI<5 cm and OR 4.63 
indicates chances of having babies with birth weight <2.5kg is 4.63 
times higher in a patients with AFI 5-8cm  and OR 7.022 indicates 
chances of having babies with birth weight <2.5kg is 7.022 times higher 
in patients with AFI>25cm compared to the patients with AFI level 8.1-
25 cm. 
TABLE:8 
 
IUGR IN RELATION TO AFI 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Total Cases 
1500 147 360 975 18 
IUGR 48  
(32.65%) 
39  
(10.8%) 
9  
(2.76%)  
 
χ2 = 230.995 df=3 pvalue: <0.001 
AFI(cm)   OR       95%CL 
      Lower   Upper 
<5    52.04   24.79   109.224 
5-8   13.04    6.249   27.215 
>25    -        -            - 
 The patients with AFI <5 cm had 32.65% of IUGR babies and 
patients with AFI 5-8cm had 10.8% of IUGR babies whereas patients 
with AFI group 8.1-25 cm had only 2.76%  of IUGR babies. None of the 
patient had IUGR babies in polyhydramnios group. 
 OR 52.04 indicates chances of having IUGR babies is 52.04 times 
in AFI<5 group and OR 13.04 indicates chances of having IUGR babies 
is 13.04 times higher in AFI 5-8 group compared to group with AFI 8.1-
25cm. 
TABLE:9 
 
AFI & MALFORMATION DIAGNOSED POSTNATALLY 
 
AFI <5 cm 5-8 
cm 
8.1-25 cm >25 cm 
Live Birth 147 36
0 
975 18 
Malformatio
n 
3 (2.04%) 
1.CTEV-
1case 
 2.PUJ 
obstruction
-2 cases 
 
    - 4  (0.41%) 
1.Polydactyl
y 
2.Duodenal 
atresia 
3.Ambiguous 
genitalia 
4.Spinabifida 
6 (33.33%) 
1.Hydrops-1 case 
2.Duodenal atresia-1 
case 
3.Spinabifida-2 cases 
4.Meningomyelocele
-2cases 
 
 
 
χ2 = 228.71  df=3 pvalue:<0.001 
 
 Among the patients with AFI>25 cm, 33.33% had babies with 
congenital malformations, 2.04% of patients with AFI<5 cm had 
congenital malformations whereas only 0.41% of patients with AFI 8.1-
25 cm had babies with  congenital malformations diagnosed postnatally, 
which gives a ‘p’ value of 0.001 which is significant. 
 
 TABLE:10 
 
AFI & NICU ADMISSION 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Live Birth 147 360 975 18 
NICU 
Admission 
75  
(51.02%) 
78  
(21.66%) 
93  
(9.53%) 
8  
(44.44%) 
 
χ2=174.55 df=3 pvalue:<0.001 
 
AFI(cm)    OR  95% CL 
     Lower  Upper 
<5      9.879 1.705   14.556 
5-8   2.623  1.887   3.647 
>25   7.587   2.923  19.695 
 Rate of admission of babies to NICU was greater in those with 
decreased & increased AFI compared to normal. 
 OR 9.8 indicates chance of having NICU admission is 10 times 
higher in AFI<5 group, OR 2.6 indicates, NICU admission is 3 times 
higher in AFI 5-8 group, OR 7.5 indicates NICU admission is 7.5 times 
higher in AFI>25 cm group compared to AFI group of 8.1-25cm. 
 
 TABLE:11 
 
AFI & NEONATAL DEATH 
 
AFI <5 cm 5-8 cm 8.1-25 cm >25 cm 
Live Birth 147 360 975 18 
Neonatal 
Death 
7  
(4.76%) 
8  
(2.2%) 
12  
(1.23%) 
6  
(33%) 
 
χ2 =89.831 df=13      pvalue<0.001 
  AFI(cm)     OR       95% CL 
     Lower   Upper 
<5   4.012  1.554   10.36 
5-8   1.82  0.739   4.49(NS) 
>25   40.125 12.98   124.63 
 
 Neonatal death was 4.76% in group with AFI<5 cm,2.2% in 
group with AFI 5-8cm, 33% in group with AFI >25 cm and only 1.23% 
in group with AFI 8.1-25cm. 
 OR of 4.012 indicates chance of having neonatal death is nearly 4 
times higher in AFI group <5 cm, OR 1.82 indicates, chance of having 
neonatal death is nearly 2 times higher in AFI group 5-8cm. 
 OR of 40.125 indicates, chance of having neonatal death is only 
40 times higher in AFI group>25cm. 
 DISCUSSION 
 
Quantitative amniotic fluid volume determination by AFI is now a 
routine part of fetal biological profile score testing. The relationship 
between oligohydramnios and poor perinatal outcome has been 
previously documented. This descriptive follow-up study was 
undertaken to review the relation between AFI and neonatal outcome 
and effect of AFI on labour in 1500 antenatal patients with term 
gestation. Of 1500 cases 147 had AFI<5cm,360 had AFI within the 
range of 5-8cm,975 had AFI in the range of 8.1-25cm and 18 had 
polyhydramnios with AFI>25cm. 
In our study when the AFI was less than 5cm,the nonreassuring 
fetal heart pattern was seen in57.14%. 23.33% of patients had 
nonreassuring fetal heart pattern in group with AFI 5-8cm. 8% of 
patients had nonreassuring fetal heart pattern in the AFI group 8.1-25 
cm and 16.66 of patients had nonreassuring fetal heart pattern in the AFI 
group >25 and ‘p’ value is <0.001 which is statistically significant. 
In our study when the AFI was < 5cm the caesarean section rate 
was 34% and the instrumental delivery was 8.16%.The incidence of 
induced and instrumental delivery (16.32% and 18.16%respectively) 
was significantly higher in the group with AFI < 5 cm compared to the 
group with AFI 8-25 cm (7.38% and 4.92%) .Less patients with 
oligohydramnios were allowed SPVD (8.16%) compared to 56.87% 
with normal AFI 8.1-25cm and 66.66% in the group of AFI > 25 cm (‘p’ 
value is < 0.001) 
In our study, the incidence of SPVD was only 46.66% in the AFI 
group 5-8cm compared to 67.07% with AFI group 8-25cm.Among the 
cases taken up for caesarean section, fetal distress was the commonest 
indication.57.14% of patients with AFI >5, 25.83% of patients with AFI 
5-8cm were taken up for caesarean section for fetal distress compared to 
only 12.92% in those with AFI 8-25 cm. 
With respect the association between meconium staining and AFI 
it was concluded in our study that 38.68% of the patients with AFI of 0-
5 cm,there was meconium staining of the amniotic fluid. The study done 
by Chauhan et al ,1999 showed that in borderline AFI, 12% of the 
patients had meconium staining liquor with 95% CL of 0.64-5.89 which 
was statistically not significant, whereas in our study the ‘p’ value is 
<0.001 and χ2 value was 360.4. With respect to the association between 
AFI and Apgar at 5mts it was concluded in our study, Apgar at 5mts 
was poorer in patients with AFI<5 (51.02%) unlike 14.843% with 
AFI>5cm 
In our study the group with AFI 5-8 cm had 25% babies with 
Apgar <5 compared to 13.33% with AFI group 8.1-25 cm and 33.33% 
in the AFI group >25cm. 
Taking into consideration of birth weight and IUGR in association 
with AFI, we can conclude from our study that there is higher incidence 
of IUGR and low birth weight babies when the AFI < 5 cm.The 
incidence of low birth weight babies and IUGR was significantly much 
greater in the group AFI 5-8 cm compared to the group with AFI 8.1-25 
cm..’p’ value is <0.001 making it statistically significant. The study 
done by  Chauhan et al showed the mean birth weight of 3.3kg with 
variation of 500grams and ‘p’ value is < 0.001. Mean birth weight of 
babies in our study was 3.1kg. 
We have also studied the occurrence of congenital malformations 
which were not diagnosed antenatally and their association with AFI. 
Incidence was maximum in polyhydramnios (33.33%) ‘p’ value is < 
0.001 which is statistically significant. 
Studying the association between the AFI and neonatal morbidity 
and mortality we find highest morbidity in the AFI group < 5 cm 
followed by group AFI > 25 cm. Neonatal deaths were maximum in the 
AFI group > 25(33%) and this was largely due to congenital 
malformations. 
 
 
SUMMARY 
1. This study entitled, ‘Amniotic fluid index-Effect on Labour and 
Neonatal Outcome’ was done at Government Hospital for Women 
and Children, Egmore, Chennai between June 2006 to  June2007. 
2. This study was done with the aims and objectives of screening of 
antenatal patients at term for oligohydramnios or polyhydramnios 
and subjecting them to ultrasound examination to determine the 
amniotic fluid index by four-quadrant method and to study the 
effect of AFI on labour and neonatal outcome. 
3. This was a descriptive follow-up study. 1500 antenatal patients 
were included in this study. They were categorized into 4 groups 
as AFI < 5 cm, AFI 5-8 cm, AFI 8.1- 25 cm and AFI >25 cm. 
4. All the studies done in this subject were extensively studied and 
analyzed and they were incorporated in the review of literature. 
5. Measurement of outcomes included were incidence of non 
reactive NST, caesarean delivery for fetal distress, meconium 
staining, Apgar score <7 at 5 mts, birth weight < 2.5kg,IUGR, 
admission to NICU and neonatal death. 
6. The various parameters, which were noted in our patients, were 
incorporated into proforma which is enclosed and which formed 
the basis of detailed discussion. 
7. Incidence of caesarean section for fetal distress is highest in AFI 
<5 cm followed by AFI group 5-8 cm. 
8. Neonatal morbidity and mortality is highest in AFI <5 cm 
followed by AFI group 5-8 cm. 
9. Incidence of congenital malformations, which were diagnosed 
postnatally, was maximum in polyhydramnios group (AFI > 
25cm). 
 
 
 
CONCLUSIONS 
1. This study suggests that AFI is a good predictor of neonatal 
morbidity and mortality as has been classically reported.The 
findings of this study are consistent with previous retrospective 
studies by Garmel et al who showed that there was significant 
increase in risk of caesarean delivery, fetal distress and low birth 
weight with oligohydramnios. 
2. The AFI for detecting intrapartum oligohydramnios is a valuable 
screening test for subsequent fetal distress requiring caesareasn 
delivery. 
3. There was an increased risk of nonreassuring fetal heart rate 
pattern during labour for oligohydramnios patients. 
4. Significantly  higher incidence of IUGR was found in women 
with low  AFI as compared to women with normal AFI 
5. Our data are consistent with reports of other investigations and 
suggest that the AFI of 5-8 cm should be an indication of twice 
weekly antepartum testing. 
6. A border line AFI of 5-8 cm may be early marker of declining 
placental function and progressing fetal compromise and AFI 
measurements may provide an early dependent marker 
independent of weight and gestational age. 
7. The possibility of fetal distress is much higher in the AFI group < 
5 cm and 5-8 cm hence vigilance and early decision is important 
in these groups. Pregnancies with oligohydramnios and 
compromised fetuses are more likely to be terminated earlier than 
pregnancies with normal AFI and healthy appearing fetus. Any 
sign of deteriorating fetal condition may prompt immediate 
delivery. This selective censoring (or confounding by indication) 
may some extent have biased the time dependant outcomes (e.g. 
perinatal outcomes) towards better results in cases in 
oligohydramnios. 
8. Neonatal morbidity and mortality is highest in AFI < 5 cm but 
there is significant neonatal morbidity and mortality in the AFI 
group of 5-8 cm and hence this group cannot be considered as 
normal even though the definition by Moore TR 1997 states that 
normal AFI is 5-25cm 
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PROFORMA 
The study of neonatal morbidity,mortality and labour in relation 
to amniotic fluid index in 1500 cases of normal pregnancies. 
Name 
Wife of 
Address 
Age 
I.P/O.P No 
Socio economic status 
Booked / Unbooked 
D.O.A. 
LMP 
EDD 
Obstetric formula   G P L A 
Complaints (if any) 
Present  Obstetric  History 
Past obstetric History  
Menstrual History :     Age at menarche 
         Duration of cycle 
         Regular/irregular  
Past Medical History: H/o TB, DM, HT, HD, Epilepsy,   
                     Bronchial Asthma 
Past surgical History: 
Family History: 
Personal History: Diet, Nutrition, Sleep, Bowels & Micturition 
H/o cigarette    smoking, Alcohol  
General examination: 
Height:    Weight: 
Nutritional Status  
Pallor         
Pedal Oedema 
Breast 
Thyroid 
Spine 
Gait 
Vitals:     Temperature: P.R 
     B.P   R.R. 
Systemic Examination:  CVS:  RS:  CNS: 
Local Examination:   Fundal grip 
Umblical grip 
Pelvic grips 
     Amount of liquor 
Per Vaginal Examination:  Leaking membranes 
      Bishops Score 
Pelvis 
Investigations:   Hb% 
     Urine examinations   
Blood Group & Type 
     Random Blood Sugar 
     HIV & VDRL     
Admission CTG 
Early USG in first trimester 
Ultrasonography:   Presentation  
     Gestational Age 
     Amniotic fluid index 
  Rt upper  Lt Upper 
  Rt lower  Lt lower 
     Placental position and grading 
Details Of Delivery: 
Duration of First Stage 
         Second Stage 
               Third stage 
 Mode of delivery: Vaginal: Spontaneous / Induced 
Forceps:  Indication 
    LSCS:           Indication 
  Colour of Liquor: Clear / meconium 
Baby Details:  Live / Still Birth 
    Term/Preterm 
    Date and Time of birth 
    Birth wt  HC 
    Gestational age 
    Sex 
    Apgar Score at 1 mt 
       5 mt 
    Any congenital anomalies 
   Admission to NICU:  Yes / No 
   No. of days in NICU 
   Oxygen / Ventilator support 
   I.V. Antibiotics  Yes / No 
    CXR  Yes / No 
   Condition at the time of discharge 
NEONATAL OUTCOME: 
   Healthy / neonatal Death 
 
ABBREVIATION 
 
A  - Admission 
AFI  - Amniotic Fluid Index 
AFV  -  Amniotic Fluid Volume 
AT  - Admission Test 
BPP  - Biophysical Profile 
C  -  Clear 
CPD  - Cephalopelvic Disproportion  
FD  - Fetal Distress 
FHR  - Fetal Heart Rate 
FI  - Failed Induction  
FT  - Full Term  
HIE  - Hypoxic Ischemic Encephalopathy 
IUGR  - Intrauterine Growth Retardation  
LMC  - Low Midcavity Forceps  
LSCS  - Lower Segment Caesarean Section 
MAS  - Meconium Aspiration Syndrome  
NR  - Nonreactive  
NST  - Non Stress Test 
RD  - Respiratory Distress 
SPVD - Spontaneous Vaginal Delivery 
USG  - Ultrasonogram  
VD  - Vaginal Delivery 
 
